The Effects of TNF Inhibitors on Psoriasis

MIRICISM-AB is another anti-IL-23 monoclonal antibody. Lilly's drug got a good splash this week with a very effective phase two trial and ulcer colitis patients. There seems to be no safety signals or efficacy worries here, it's just that they need more time, I believe, to actually do the analysis.